Top Markets
Coin of the day
Aceragen, Inc. Aceragen, Inc.

Aceragen, Inc.

ACGN
株式のランク #39037
Aceragen, Inc., a biopharmaceutical firm in its clinical development phase,... Aceragen, Inc., a biopharmaceutical firm in its clinical development phase, operates out of Exton, Pennsylvania, and was founded in 1989. The company, which transitioned from Idera Pharmaceuticals, Inc. and adopted its current name in January 2023, concentrates on the discovery, advancement, and bringing to market of therapeutic agents for uncommon lung and autoimmune conditions exclusively within the United States. Its product development pipeline includes ACG-701, currently undergoing Phase 2 clinical evaluation for both cystic fibrosis pulmonary exacerbations and melioidosis, as well as ACG-801, which is being developed to address Farber disease. Moreover, Aceragen maintains a partnership and option agreement with Scriptr Global, Inc. This collaboration aims to pinpoint, research, and cultivate gene therapy options intended for the management, palliation, diagnosis, or prevention of myotonic dystrophy type 1 and Friedreich's Ataxia.
株価
$0.38
最終同期: 2023-09-01
時価総額
$677.16K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Aceragen, Inc. (ACGN)

カテゴリー

Aceragen, Inc.(ACGN)の株価履歴
終値の最高値: $0.38 (2023-09-01)

終値の最安値: $64.33K (1996-01-01)
Aceragen, Inc. の株価履歴(1996 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2023 -92.15%
2022 -56.36%
2021 -85.30%
2020 156.42%
2019 -62.29%
2018 -71.51%
2017 25.28%
2016 -54.63%
2015 -10.86%
2014 28.19%
2013 290.03%
2012 -27.35%
2011 -57.65%
2010 -48.14%
2009 -35.84%
2008 -34.66%
2007 126.13%
2006 11.76%
2005 25.16%
2004 -60.39%
2003 51.06%
2002 -54.68%
2001 218.06%
2000 -48.13%
1999 -40.76%
1998 -61.27%
1997 -85.90%
1996 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$517.18 32.51%
US
$857.76 31.47%
NL
$728.05 6.60%
CH
$1.07K -6.40%
KR
$254.79 12.56%
BE